These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 7781688
1. 5-Carboxamidotryptamine attenuates the development of deoxycorticosterone acetate-salt hypertension in rats. Balasubramaniam G, Lee HS, Mah SC. Eur J Pharmacol; 1995 Mar 24; 276(1-2):183-90. PubMed ID: 7781688 [Abstract] [Full Text] [Related]
3. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats. Takaoka M, Kobayashi Y, Yuba M, Ohkita M, Matsumura Y. Eur J Pharmacol; 2001 Jul 20; 424(2):121-9. PubMed ID: 11476758 [Abstract] [Full Text] [Related]
4. Blood pressure and renal responses to synthetic rat atrial natriuretic factor in deoxycorticosterone acetate-salt hypertension. Kohzuki M, Abe K, Yasujima M, Kasai Y, Hiwatari M, Kanazawa M, Sato M, Omata K, Kudo K, Takeuchi K. Tohoku J Exp Med; 1989 Apr 20; 157(4):301-11. PubMed ID: 2525826 [Abstract] [Full Text] [Related]
7. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats. O'Donaughy TL, Qi Y, Brooks VL. Hypertension; 2006 Oct 20; 48(4):658-63. PubMed ID: 16966581 [Abstract] [Full Text] [Related]
9. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Li JS, Turgeon A, Schiffrin EL. Am J Hypertens; 1998 May 20; 11(5):554-62. PubMed ID: 9633791 [Abstract] [Full Text] [Related]
11. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats. Nishimura M, Ohtsuka K, Sakamoto M, Nanbu A, Takahashi H, Yoshimura M. J Hypertens; 1998 Aug 20; 16(8):1175-85. PubMed ID: 9794722 [Abstract] [Full Text] [Related]
13. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism. Ammarguellat F, Larouche I, Schiffrin EL. Circulation; 2001 Jan 16; 103(2):319-24. PubMed ID: 11208696 [Abstract] [Full Text] [Related]
14. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors. Silva AL, Cabral AM, Abreu GR, Pires JG, Bissoli NS, Ramage AG. Eur J Pharmacol; 2005 Aug 22; 518(2-3):152-7. PubMed ID: 16014306 [Abstract] [Full Text] [Related]
15. Chronic central potassium infusion prevents deoxycorticosterone-salt hypertension in rats. Klarr SA, Keep RF, Betz AL. Am J Physiol; 1995 Feb 22; 268(2 Pt 2):H646-52. PubMed ID: 7864190 [Abstract] [Full Text] [Related]
16. Effects of salt and DOCA on hypothalamic and baroreflex control of blood pressure. Takeda K, Nakamura Y, Hayashi J, Kawasaki S, Nakata T, Oguro M, Sasaki S, Nakagawa M. Clin Exp Hypertens A; 1988 Feb 22; 10 Suppl 1():289-99. PubMed ID: 3242995 [Abstract] [Full Text] [Related]
17. Increased sensitivity to norepinephrine cardiac arrhythmias in the deoxycorticosterone acetate high salt rat before the onset of hypertension. Rabkin SW, Fung AY. Can J Physiol Pharmacol; 1984 Jun 22; 62(6):605-9. PubMed ID: 6744105 [Abstract] [Full Text] [Related]
18. Development of hypertension in animals with reduced total peripheral resistance. Huang M, Hester RL, Coleman TG, Smith MJ, Guyton AC. Hypertension; 1992 Dec 22; 20(6):828-33. PubMed ID: 1452299 [Abstract] [Full Text] [Related]
19. Cardiac output and the blood pressure increase in deoxycorticosterone acetate-salt hypertension after nicotine infusion. Passmore JC, Jimenez AE, Pierce WM. Clin Exp Hypertens A; 1991 Dec 22; 13(1):83-102. PubMed ID: 2022074 [Abstract] [Full Text] [Related]
20. Chronic activation of central alpha2-adrenoceptors prevents hypertension in DOCA-salt rats. Cabral AM, da Silva IF, Gardioli CR, Menegaz RG. Auton Neurosci; 2000 Aug 14; 82(3):146-53. PubMed ID: 11023621 [Abstract] [Full Text] [Related] Page: [Next] [New Search]